⚡ Quick Answer — What is Cyblex MV?
Cyblex MV is een triple-drug fixed-dose combination van metformin, gliclazide and voglibose (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) used for diabetes type 2 not controlled on dual therapy. Three complementary mechanisms in a single tablet: metformin reduces hepatic glucose production; gliclazide (a second-generation sulfonylurea) stimulates insulin release; voglibose slows intestinal carbohydrate absorption to blunt post-meal spikes. Typical HbA1c reduction: 2.0–2.5 points. Usual dose: one tablet 1–3 times daily with the first bite of each main meal. Side-effect profile combines hypoglycaemia risk (gliclazide), GI flatulence/bloating (voglibose), and metformin GI upset. Hypoglycaemia rescue requires glucose (dextrose) tablets, not table sugar (voglibose blocks sucrose breakdown). Avoid in type 1 diabetes, eGFR < 30, IBD, severe hepatic impairment, and sulfa allergy.
📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.
Waarom bestellen bij MedsBase
Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.
What Is Cyblex MV?
Cyblex MV is an oral fixed-dose combination tablet containing three active antidiabetic ingredients: metformin, gliclazide and voglibose (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg). Manufactured by WHO-GMP certified manufacturer. Available in packs of 30, 60, 90 or 180 tablets. It is used in adults with type 2 diabetes when dual therapy is not enough and the clinician wants to intensify oral treatment before starting insulin.
The three-way combination is especially useful in people with a predominantly carbohydrate-rich diet (Asian populations) where post-meal glucose spikes are a major driver of HbA1c.
How Does Cyblex MV Work?
Cyblex MV targets hyperglycaemia through three completely separate mechanisms:
- Metformine — reduces hepatic glucose production (activates AMPK), improves insulin sensitivity in muscle/fat, slightly slows intestinal glucose absorption. Does not cause hypoglycaemia on its own.
- Gliclazide — a second-generation sulfonylurea. Closes KATP channels on pancreatic beta cells, triggering insulin release. Gliclazide has the best cardiovascular-safety profile in its class (ADVANCE trial).
- Voglibose — an alpha-glucosidase inhibitor that slows carbohydrate breakdown in the gut, reducing the post-meal glucose spike. Acts locally in the gut lumen; minimal systemic effect.
Combined HbA1c reduction: 2.0–2.5 percentage points. The combination covers fasting, post-meal, and overall insulin-resistance contributions to hyperglycaemia in one tablet.
Dosering en toediening
één tablet tweemaal daags, bij het ontbijt en avondeten. De dosering wordt individueel bepaald op basis van eerdere therapie, HbA1c-streefniveau en nierfunctie. one tablet taken with the first bite of each main meal (once, twice, or three times daily depending on prior regimen and HbA1c target).
- Take with the first bite — voglibose must be ingested with food to act; gliclazide needs a meal to avoid hypoglycaemia; metformin is best tolerated with food.
- Skip the dose if you skip the meal — especially important because of the gliclazide component.
- Hypoglykemie behandeling: always use pure glucose (dextrose) tablets or gel, not table sugar or fruit juice — voglibose blocks sucrose breakdown in the gut.
- Renale dosering: avoid if eGFR < 30. Reduce dose if eGFR 30–45.
- Stop voor IV-contrast, operatie of acute ziekte met uitdroging.
- Monitor glucose, HbA1c, weight, renal function, and vitamin B12 annually.
Bijwerkingen
Van metformine (eerste 1–2 weken): diarrhoea, nausea, abdominal cramps, metallic taste.
From gliclazide:
- Hypoglykemie — gliclazide has the lowest hypoglycaemia risk among sulfonylureas, but it is still possible.
- Modest weight gain (1–2 kg)
- Af en toe huiduitslag
From voglibose: flatulence, bloating, soft stools, diarrhoea — usually improves with slow titration.
Zeldzaam maar ernstig: lactic acidosis (metformin) — very rare, almost always in AKI/sepsis/hypoxia; severe or prolonged hypoglycaemia; hepatic-enzyme elevation; rare haemolytic anaemia in G6PD deficiency.
Geneesmiddelinteracties
- Verhoogd risico op hypoglykemie: insulin, other antidiabetics, alcohol, trimethoprim/sulfamethoxazole, fluconazole, clarithromycin, ACE inhibitors, high-dose salicylates, non-selective beta-blockers (also mask symptoms).
- IV gejodeerd contrastmiddel — hold pre- and post-procedure if eGFR < 60.
- Carbonaatanhydraseremmers (acetazolamide, topiramate) — raise lactic acidosis risk.
- Kationische geneesmiddelen (cimetidine, dolutegravir, ranolazine) — verhogen metforminespiegels.
- Digestive enzyme preparations — counteract voglibose; avoid.
- Corticosteroids, thiazides, thyroid hormones, oral contraceptives, atypical antipsychotics, phenytoin, rifampicin — kunnen het glucoseverlagende effect verminderen.
Who Should Not Take Cyblex MV?
- Diabetes mellitus type 1 of diabetische ketoacidose
- Ernstig nierfalen (eGFR < 30)
- Ernstige leverfunctiestoornis
- Inflammatory bowel disease or chronic intestinal obstruction
- Allergie voor sulfonamiden (sulfa)
- Acute ziekte met risico op weefselhypoxie
- Zwangerschap en borstvoeding
- Known hypersensitivity to any component
Opslag
Store Cyblex MV below 25°C in a dry place. Keep out of reach of children.
Veelgestelde vragen
Why a triple-drug diabetes tablet?
To simplify the regimen. Patients needing metformin + sulfonylurea + alpha-glucosidase inhibitor would otherwise take three separate tablets at each meal. Combining them into one tablet improves adherence and reduces pill burden without changing the clinical effect.
If I get low blood sugar, can I just eat a sweet?
No — take pure glucose (dextrose) tablets or gel. Because Cyblex MV contains voglibose, the alpha-glucosidase inhibitor blocks the breakdown of sucrose (table sugar) and many other complex carbohydrates, so they work too slowly for a hypo. Glucose itself is absorbed directly and works within minutes.
Does Cyblex MV cause weight gain?
Modest 1–2 kg, driven by the gliclazide component. Metformin and voglibose are weight-neutral or very slightly weight-reducing, so the net effect is usually less than sulfonylurea monotherapy.
Can I drink alcohol while taking Cyblex MV?
Moderate alcohol with food is usually safe. Avoid binge drinking — raises hypoglycaemia risk (gliclazide) and lactic acidosis risk (metformin).
Should I switch to insulin?
A decision for you and your prescriber. Insulin is essential once beta-cell function is severely reduced but has its own risks (hypoglycaemia, weight gain, injections). Triple oral therapy like Cyblex MV is often tried first in motivated patients with residual beta-cell function.
Where can I buy Cyblex MV online?
You can order Cyblex MV (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.
Gerelateerde diabetesmedicatie
- Glycomet SR — Metformin monotherapy
- Glycomet-GP — Metformin + Glimepiride
- Voglibite — Voglibose monotherapy
- Glizid — Gliclazide monotherapy
- Januvia — Sitagliptin (DPP-4 alternative)
- Jardiance — Empagliflozin (SGLT-2-alternatief)
- Bekijk alle diabetesmedicatie
Gerelateerde alternatieven
Andere producten in Chronische aandoeningen die klanten ook bekijken:


























Beoordelingen
Er zijn nog geen beoordelingen